The importance of autonomy of European Union member states with regard to the use of genetically modified organisms on the right to healthcare – an analysis of judgements of the Court of Justice of the European Union

URN:NBN:SI:DOC-8E6VVWWH2022Meško Kuralt, Katjadocuments/doc/8/URN_NBN_SI_doc-8E6VVWWH_001.pdfdocuments/doc/8/URN_NBN_SI_doc-8E6VVWWH_001.txt114articlestr. 1-2810.18690/lexonomica.14.1.1-28.20221335869471855-7147URN:NBN:SI:doc-8E6VVWWHengUniversity of Maribor PressLexonomicaBYDirective 2001/18Directive 2015/4120Directive 2018/350environmental risk assessmentfree movement of goodshigh level of protection of human life and healthpossibility of restricting or prohibiting the production of GMOsThe importance of autonomy of European Union member states with regard to the use of genetically modified organisms on the right to healthcare – an analysis of judgements of the Court of Justice of the European Union